Real-World Clinical Data of Palbociclib in Asian Metastatic Breast Cancer Patients: Experiences from Eight Institutions

PURPOSE: Use of cyclin-dependent kinase 4/6 inhibitors improved survival outcome of hormone receptor (HR) positive metastatic breast cancer (MBC) patients, including Asian population. However, Asian real-world data of palbociclib is limited. We analyzed the real-world clinical practice patterns and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jieun, Park, Hyung Soon, Won, Hye Sung, Yang, Ji Hyun, Lee, Hee Yeon, Woo, In Sook, Shin, Kabsoo, Hong, Ji Hyung, Yang, Young Joon, Chun, Sang Hoon, Byun, Jae Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053880/
https://www.ncbi.nlm.nih.gov/pubmed/33138346
http://dx.doi.org/10.4143/crt.2020.451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053880/
https://www.ncbi.nlm.nih.gov/pubmed/33138346
http://dx.doi.org/10.4143/crt.2020.451

Ejemplares similares